Inmode Ltd
NASDAQ:INMD

Watchlist Manager
Inmode Ltd Logo
Inmode Ltd
NASDAQ:INMD
Watchlist
Price: 13.9158 USD -1.17% Market Closed
Market Cap: $879.6m

Operating Margin

24%
Current
Declining
by 11%
vs 3-y average of 35%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
24%
=
Operating Income
$87.4m
/
Revenue
$364.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
24%
=
Operating Income
$87.4m
/
Revenue
$364.5m

Peer Comparison

Country Company Market Cap Operating
Margin
IL
Inmode Ltd
NASDAQ:INMD
881.1m USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.7B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
134.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.6B USD
Loading...

Market Distribution

Higher than 82% of companies in Israel
Percentile
82nd
Based on 734 companies
82nd percentile
24%
Low
-84 760% — -5.8%
Typical Range
-5.8% — 10.9%
High
10.9% — 23 869.1%
Distribution Statistics
Israel
Min -84 760%
30th Percentile -5.8%
Median 4%
70th Percentile 10.9%
Max 23 869.1%

Inmode Ltd
Glance View

InMode Ltd., founded in 2008, has emerged as a dynamic player in the field of minimally invasive aesthetic medical treatments. Born during a period where the health and beauty sectors were experiencing rapid technological innovation, the company quickly carved a niche for itself by addressing a clear market need: the rising demand for non-surgical procedures. At its heart, InMode merges the precision of medical technology with the principles of aesthetic enhancement. Its primary offerings revolve around radio-frequency-based devices that healthcare providers use to achieve results that traditionally required more invasive techniques. This includes skin tightening, fat reduction, and body contouring solutions, all tailored to meet the growing consumer appetite for treatments that carry less downtime and risk compared to conventional surgery. The company monetizes its expertise by manufacturing and selling these state-of-the-art devices to a diverse group of users, ranging from dermatologists and plastic surgeons to aesthetic practices. InMode's revenue streams are bolstered by not only the direct sale of these devices but also by ongoing client relationships through service agreements and consumable products that are essential for their machine operation. It is a model that ensures continuous engagement with their clients, providing both stability and growth in revenue. By focusing on innovation and efficacy, InMode has successfully captured a significant share of the aesthetic medical market, embodying a business strategy that combines cutting-edge technology with practical solutions to consumer needs.

INMD Intrinsic Value
18.032 USD
Undervaluation 23%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
24%
=
Operating Income
$87.4m
/
Revenue
$364.5m
What is Inmode Ltd's current Operating Margin?

The current Operating Margin for Inmode Ltd is 24%, which is below its 3-year median of 35%.

How has Operating Margin changed over time?

Over the last 3 years, Inmode Ltd’s Operating Margin has decreased from 44.6% to 24%. During this period, it reached a low of 24% on Sep 30, 2025 and a high of 44.6% on Sep 30, 2022.

Back to Top